Syn2bio SA (S2BP)

Currency in PLN
66.60
+4.40(+7.07%)
Delayed Data·
Advertisement
Earnings results expected in 9 days
S2BP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
62.4471.79
52 wk Range
26.2096.60
Key Statistics
Bid/Ask
66.60 / 67.45
Prev. Close
62.2
Open
62.54
Day's Range
62.44-71.79
52 wk Range
26.2-96.6
Volume
90.65K
Average Volume (3m)
71.18K
1-Year Change
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
S2BP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
31.00
Downside
-53.45%
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a poor free cash flow yield

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 31.00
(-53.45% Downside)

Earnings

Latest Release
03/06/2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

Compare S2BP to Peers and Sector

Metrics to compare
S2BP
Peers
Sector
Relationship
P/E Ratio
0.0x−9.4x−0.4x
PEG Ratio
0.000.030.00
Price/Book
0.0x2.5x2.6x
Price / LTM Sales
0.0x7.5x3.1x
Upside (Analyst Target)
0.0%60.9%48.6%
Fair Value Upside
Unlock−3.3%5.8%Unlock

Syn2bio S.A. operates as a biotechnology company. It engages in the development and commercialization of SYN2 cardiotracer, a radiopharmaceutical designed for testing myocardial perfusion and diagnosis of coronary artery disease. It also engages in the research of new pharmaceutical compounds and its further study, registration, and market launch as a medicinal product. Syn2bio S.A. was incorporated in 2025 and is based in Warsaw, Poland.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
71.89K0.82%4.47M
Other Institutional Investors
0.000.00%0.00
Public Companies & Retail Investors
8.66M99.18%538.48M
Total
8.73M100.00%542.95M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Dimensional Fund Advisors LP0.78%68,0424,232
DFA Investment Dimensions Group Inc. - Emerging Markets Core Equity 2 Portfolio0.40%34,5002,146

People Also Watch

0.5600
EXCP
-5.88%
25.00
ARL1
-0.40%
4.980
GKI
-0.40%
14.40
TRNP
+0.70%

FAQ

What Is the Syn2bio (Warsaw: S2BP) Share Price Today?

The Syn2bio stock price today is 66.60 PLN.

What Stock Exchange Does Syn2bio (S2BP) Trade On?

Syn2bio is listed and trades on the Warsaw Stock Exchange.

What Is the Ticker (Stock Symbol) for Syn2bio?

The stock symbol (also called a 'ticker') for Syn2bio is "S2BP."

What Is the Current Syn2bio Market Capitalisation?

As of today, Syn2bio (Warsaw: S2BP) market cap is 542.95M PLN.

When Is the Next Syn2bio Earnings Date?

Syn2bio's next earnings report will be released on 02/09/2026.

Is S2BP a Buy or Sell From a Technical Analyst Perspective?

Based on today's Syn2bio moving averages and other technical indicators, the daily buy/sell signal for S2BP stock is Neutral.

How Many Times Has Syn2bio Stock Split?

Syn2bio has split 0 times. (See the S2BP stock split history page for full effective split date and price information.)

What is the current trading status of Syn2bio (Warsaw: S2BP)?

As of 24/08/2026, Syn2bio (S2BP) is trading at a share price of 66.60 PLN, with a previous close of 62.20 PLN. The stock has fluctuated within a day range of 62.44 PLN to 71.79 PLN, while its 52-week range spans from 26.20 PLN to 96.60 PLN.

What Is Syn2bio (S2BP) Price Target According to Analysts?

The average 12-month price target for Syn2bio is 31.00 PLN, with a high estimate of 31 PLN and a low estimate of 31 PLN. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an -53.45% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.